Virios Therapeutics Inc.

0.15
0.01 (8.77%)
At close: Oct 08, 2024, 8:00 PM

Virios Therapeutics Statistics

Share Statistics

Virios Therapeutics has 1.33M shares outstanding. The number of shares has increased by -95.2% in one year.

Shares Outstanding 1.33M
Shares Change (YoY) -95.2%
Shares Change (QoQ) 0%
Owned by Institutions (%) 5.12%
Shares Floating 1.04M
Failed to Deliver (FTD) Shares 12.07K
FTD / Avg. Volume 13.75%

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Valuation Ratios

The PE ratio is -50.98 and the forward PE ratio is null. Virios Therapeutics's PEG ratio is 0.68.

PE Ratio -50.98
Forward PE n/a
PS Ratio 0
Forward PS null
PB Ratio 70.92
P/FCF Ratio -55.44
PEG Ratio 0.68
Financial Ratio History

Enterprise Valuation

Virios Therapeutics has an Enterprise Value (EV) of 266.68M.

EV / Sales 0
EV / EBITDA 1767.23
EV / EBIT -54.75
EV / FCF -54.75

Financial Position

The company has a current ratio of 11.62, with a Debt / Equity ratio of 0.

Current Ratio 11.62
Quick Ratio 11.62
Debt / Equity 0
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is -139.12% and Return on Invested Capital is -142.93%.

Return on Equity -139.12%
Return on Assets -127.14%
Return on Invested Capital -142.93%
Revenue Per Employee $0
Profits Per Employee $-1.32M
Employee Count 4
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -5.45K
Effective Tax Rate 0.1%

Stock Price Statistics

The stock price has increased by -98.59% in the last 52 weeks. The beta is 1.58, so Virios Therapeutics's price volatility has been higher than the market average.

Beta 1.58
52-Week Price Change -98.59%
50-Day Moving Average 4.41
200-Day Moving Average 7.21
Relative Strength Index (RSI) 51.55
Average Volume (20 Days) 87.79K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -5.45M
Net Income -5.3M
EBITDA 150.9K
EBIT n/a
Earnings Per Share (EPS) -0.28
Full Income Statement

Balance Sheet

The company has 3.32M in cash and 0 in debt, giving a net cash position of 3.32M.

Cash & Cash Equivalents 3.32M
Total Debt 0
Net Cash 3.32M
Retained Earnings -61.47M
Total Assets 3.64M
Working Capital 3.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.87M and capital expenditures 0, giving a free cash flow of -4.87M.

Operating Cash Flow -4.87M
Capital Expenditures 0
Free Cash Flow -4.87M
FCF Per Share -0.26
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

VIRI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -1.96%
FCF Yield -1.8%
Dividend Details

Analyst Forecast

The average price target for VIRI is $15, which is 9900% higher than the current price. The consensus rating is "Hold".

Price Target $15
Price Target Difference 9900%
Analyst Consensus Hold
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score -29.81
Piotroski F-Score 1